Colleen Delaney
![Colleen Delaney Colleen Delaney](https://allogeneic-cell-therapies.com/wp-content/uploads/sites/36/2024/01/Colleen-Delaney-Speaker-150x150.png)
Company: Deverra Therapeutics
Job title: Founder and Chief Scientific Officer, EVP of Research and Development
Seminars:
Panel Discussion: What Criteria Make the Ideal Starting Material for Allogeneic Products? 3:40 pm
View the full event guide for more detailsRead more
day: Manufacturing Track Day One PM
Overcoming Hurdles in Allogeneic Cell Therapy Development Using Pooled Donor Cord Blood CD34+ Cells as the Starting Material 5:30 pm
View the full event guide for more detailsRead more
day: Conference Day One